Key Takeaways
- Angiotensin II receptor blockers (ARBs), especially losartan, valsartan, and irbesartan, are the blood pressure medicines most commonly recalled due to impurities.
- Impurities such as NDMA, NDEA, and NMBA are probable human carcinogens and were found in some active pharmaceutical ingredients or finished tablets.
- Not all blood pressure medicines are affected; recalls are specific to products, lots, and manufacturers.
- If your medication is recalled, continue taking your blood pressure medicine unless instructed otherwise by a healthcare professional, and switch or return the recalled product as directed.
- Check FDA recall lists, your pharmacy, and your prescriber if you are unsure; never stop or change therapy on your own.
Why Blood Pressure Medicines Are Recalled
Recalls of blood pressure medicines typically occur when impurities that were not intentionally added are found in the active pharmaceutical ingredient (API) or finished tablets. These impurities may originate from changes in manufacturing processes, raw material sourcing, storage conditions, or degradation over time. Regulators issue recalls when the levels of these substances exceed accepted safety standards, even though the medicines remain effective at controlling blood pressure.
The most frequent contaminants in recalled blood pressure drugs are nitrosamines, which are classified as probable human carcinogens. The most relevant are N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), and N-methyl-N-nitrosobutyramine (NMBA). Because these compounds may increase cancer risk over long-term exposure, health authorities treat them with caution and remove affected products from pharmacy shelves.
Common Sources of Impurities
- Changes in raw material suppliers or chemical reagents used in synthesis.
- Byproducts of the chemical reactions during API production.
- Degradation products that form if storage conditions such as temperature and humidity are not controlled.
- Variations in manufacturing equipment or cleaning processes that allow cross-contamination.
Which Blood Pressure Medicines Have Been Recalled
The blood pressure medicines most often involved in recalls are angiotensin II receptor blockers (ARBs) containing losartan, valsartan, or irbesartan. Some other ARBs and related compounds have also been affected when impurity levels were found above acceptable thresholds. Notably, not every formulation or brand of these drugs is recalled; recalls are specific to particular products, strengths, and lot numbers.
Below is a compact overview based on widely reported regulatory actions through 2024. Recall status can change quickly, so always verify with official sources before making any medication changes.
| Medicine/Active Ingredient | Typical Reason for Recall | Source Type |
|---|---|---|
| Losartan potassium | NDMA impurity in API or tablets | Regulatory agency tests |
| Valsartan | NDMA and/or NMBA impurity | Regulatory agency tests |
| Irbesartan | NDMA impurity | Regulatory agency tests |
| Hydrochlorothiazide (HCTZ) and combination products | NDMA impurity in API or tablets | Regulatory agency tests |
| Olmesartan | Occasional impurity findings leading to recall | Regulatory agency tests |
How to Interpret a Recall Notice
Official recall notices specify the exact product name, strength, manufacturer, and lot number(s) affected. If your medication matches these details, the recommended next step is to contact your pharmacist or prescriber. Many patients can switch to a different formulation or lot without interrupting blood pressure control.
How to Check if Your Blood Pressure Medicine Is Recalled
Because recalls are tied to specific lots and manufacturers, the most reliable way to check is to compare your medication label to official lists and consult your pharmacist.
- Examine your prescription bottle or package for the product name, strength, and lot number.
- Visit the FDA’s recall list page for drugs or search the FDA’s Enforcement Reports using keywords such as losartan, valsartan, irbesartan, or hydrochlorothiazide.
- Call your pharmacy; they can often pull up your prescription and confirm whether your specific lot is on recall.
- Check the manufacturer’s website if a recall is announced there.
- Ask your prescriber or a healthcare professional if you are unsure.
Online tools and pharmacy notices can help, but the most authoritative information comes from official regulatory sources and your pharmacist, who can see the exact product data.
Practical Steps if Your Medication Is Recalled
Discovering that your blood pressure medicine has been recalled can be concerning, but the most important actions are measured and safe. The goals are to maintain blood pressure control, avoid unnecessary gaps in therapy, and follow guidance from your prescriber and pharmacist.
Immediate Actions
- Do not stop taking your medication abruptly unless instructed by a healthcare professional.
- Contact your pharmacist right away; they may switch you to a different lot or an alternative medication.
- Check the recall notice for recommended next steps; some notices request patients to return the product to the pharmacy.
Follow-Up and Monitoring
- Schedule a follow-up reading with your clinician or pharmacist if you recently changed medications or had a recent high reading.
- Keep track of any new symptoms and report them to your clinician, especially if you have concerns about side effects from a replacement medication.
- Continue regular blood pressure monitoring at home or at a clinic as advised.
Long-Term Considerations and Alternatives
Blood pressure management often includes multiple medication options across different classes, so a recall typically does not mean you cannot achieve control. Common alternative classes include ACE inhibitors, angiotensin II receptor blockers (if the specific ARB is affected), calcium channel blockers, and thiazide-type diuretics. Which option is right for you depends on your overall health, kidney function, other medications, and prior responses.
When one ARB is recalled, clinicians may choose another ARB not implicated in the recall, or they may switch you to a different class if there are concerns about repeated issues. Generic versions and different manufacturers can provide more stable supply, but it is still important to verify that any new lot is not subject to an active recall.
When to Seek Medical Advice
Contact a healthcare professional if you are unsure whether your medication has been changed, if you experience new or worsening symptoms after switching medications, or if you have questions about recall notices. Urgent medical attention is needed only if you experience symptoms such as chest pain, shortness of breath, fainting, or severe dizziness, which may indicate a hypertensive emergency or a problem with your new medication.
For most people, recalls lead to straightforward product switches and do not disrupt long-term blood pressure control when followed up appropriately with their clinician or pharmacist.
Summary
Recalls of blood pressure medicines most often involve angiotensin II receptor blockers such as losartan, valsartan, and irbesartan due to nitrosamine impurities like NDMA. Not all blood pressure drugs or all lots are affected; each recall is specific to a product and manufacturer. You can check your medication against official recall lists, talk with your pharmacist, and continue therapy unless advised otherwise. If your medication is recalled, work with your clinician to transition safely to an unaffected medication or alternative class, and keep monitoring your blood pressure to ensure control.